Introduction
Xenotransplantation -the transplantation of animal cells, tissues or organs into humans to treat diseases, could be an alternative to other methods. Xenotransplantation products could function for prolonged periods when given to recipients who survive for many years. Xenotransplantation is a public health concern because it has the potential to infect human recipients with infectious agents that do not ordinarily infect humans, thereby introducing new infection to humans. It combines a potential benefit with a potential risk to humans that is presently unknown.
Quality control
The quality of xenotransplantation can not be guaranteed only by control of the finished product. Great emphasis should be placed on the origin and testing of the source animal, on the controls of animal facilities and animal husbandry, on the manufacturing and on the final release testing of the product. The risk of infectious disease is mainly dependent on the choice of source animal to be used. Each species will raise its own microbiological and virological concerns which should be addressed. 
Risk of infectious disease
The risks of most of the viruses and the non-viral micro-organisms can be substantially reduced or even eliminated by breeding animals in a barriered environment, where they are regularly screened for the absence of infection from a wide spectrum of viruses, bacteria, parasites et cetera. It is obvious that even breeding and keeping animals under barriered conditions may not exclude hitherto unknown viruses. It is also difficult, if not impossible, to safeguard against novel viruses that emerge for recombination events. A major concern is the potential for the occurrence and spread of unknown, as well as known, animal diseases into man. Methods to remove PERVs from the genome, are not currently available, and these viruses pose the most obvious risk at present.
Conclusions
Xenotransplantation carries a significant risk of infection, not only for the recipient but also for the population at large. It is possible that in an immunosuppressed host a xenogeneic infection may occur. Transmission of pathogens from transplanted animal cells to the human host may be involved, or new diseases may arise in the host caused by hitherto unknown pathogens. A disease may be established and transmitted to others in the community. There might also be difficulties in recognising and diagnosing such an event at an early stage of the evolvement of such new diseases.
